Cipher Pharmaceuticals Inc. Announces Executive Changes; Provides Earnings Guidance for the Second Quarter Ended June 30, 2019
The company provided earnings guidance for the second quarter ended June 30, 2019. For the quarter, the company expects total revenue in the range of $5.4 million to $5.6 million, compared with $6.95 million in second quarter 2018. The company expects earnings per share in the range of $0.04 to $0.05 compared with $0.07 in second quarter 2018.